if you or your partner(s) have been casual about paps, here's a good reason to take them seriously

The study included a total of 4,872,295 patients, with 1,281,997 in the SARS-CoV-2 infection group and 3,590,298 in the non-infection group. After propensity score matching, both groups comprised 1,281,997 patients each. Over a 3-year follow-up period, individuals with SARS-CoV-2 infection had significantly higher risks of developing HPV-related cancers compared to those without infection: a 67% increase in cervical cancer, 131% in vaginal cancer, 98% in vulvar cancer, 92% in anal cancer, and 78% in oropharyngeal cancer. Similar trends were observed for carcinoma in situ, with increased risks of 34% for cervical, 61% for vaginal, 74% for vulvar, 96% for anal, and 78% for oropharyngeal carcinoma in situ. Subgroup analyses stratified by age and race demonstrated consistent results.

emphasis mine